Patents by Inventor Kerstin Willmann

Kerstin Willmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Flow cytometric, whole blood dendritic cell immune function assay
    Patent number: 7351546
    Abstract: The invention provides a flow cytometric method for measuring dendritic cell function in whole blood, comprising: (a) contacting a whole blood sample with a dendritic cell activator; (b) adding to the sample a plurality of dendritic cell-distinguishing antibodies and at least one cytokine-specific antibody; and then (c) flow cytometrically assaying the sample for the binding of the cytokine-specific antibody by at least one distinguishable DC subset. Other assays are presented in which DC activation markers are assessed.
    Type: Grant
    Filed: August 7, 2003
    Date of Patent: April 1, 2008
    Assignee: Becton, Dickinson and Company
    Inventors: Kerstin Willmann, John F. Dunne
  • Flow cytometric, whole blood dendritic cell immune function assay
    Publication number: 20050079555
    Abstract: The invention provides a flow cytometric method for measuring dendritic cell function in whole blood, comprising: (a) contacting a whole blood sample with a dendritic cell activator; (b) adding to the sample a plurality of dendritic cell-distinguishing antibodies and at least one cytokine-specific antibody; and then (c) flow cytometrically assaying the sample for the binding of the cytokine-specific antibody by at least one distinguishable DC subset. Other assays are presented in which DC activation markers are assessed.
    Type: Application
    Filed: August 7, 2003
    Publication date: April 14, 2005
    Inventors: Kerstin Willmann, John Dunne
  • Flow cytometric, whole blood dendritic cell immune function assay
    Patent number: 6495333
    Abstract: The invention provides a flow cytometric method for measuring dendritic cell function in whole blood, comprising the steps of: (a) contacting a whole blood sample with a dendritic cell activator; (b) adding to the sample a plurality of dendritic cell-distinguishing antibodies and at least one cytokine-specific antibody; and then (c) flow cytometrically assaying the sample for the binding of the cytokine-specific antibody by at least one distinguishable DC subset.
    Type: Grant
    Filed: September 22, 1998
    Date of Patent: December 17, 2002
    Assignee: Becton Dickinson and Company
    Inventors: Kerstin Willmann, John F. Dunne